GeneSight Mental Health Monitor: Addictive Behaviors
77% of Americans have used addictive behaviors or unhealthy coping mechanisms to manage their mental health, according to Myriad Genetics nationwide survey
Medication failure leads 45% of respondents with depression and/or anxiety to turn to unhealthy coping mechanisms
Dylan Eyestone submits a cheek swab as part of the GeneSight test he took through his mental healthcare provider, Dawn Johnson. The sample is analyzed in a lab and Johnson receives a report detailing how Eyestone may metabolize or respond to certain mental health medications based on his unique DNA.
Many of Dawn Johnson’s patients are wary of taking medication for mental health conditions after dealing with the frustration of medication trial and error. The GeneSight test gives her information about which medications may require dose adjustments, may be less likely to work, or may have an increased risk of side effects based on a patient’s unique DNA.
The GeneSight Mental Health Monitor is a nationwide survey conducted online by ACUPOLL Precision Research, Inc. in February 2023 among a statistically representative sample (n=1000) of U.S. adults age 18+. The survey included a representative sample of adults diagnosed with depression and anxiety. The margin of error in survey results for the total base population at a 95% confidence interval is +/- 3%.
The 2022 data came from a nationwide survey of U.S. adults conducted online by ACUPOLL Precision Research, Inc. from Feb. 25 – March 11, 2022, among a statistically representative sample (n=1000) of adults age 18+. The margin of error in survey results for the total base population at a 95% confidence interval is +/- 3%.